Melissa A. Kinney

Melissa A. Kinney

Auto-generated profile, based on publicly available information

Melissa A. Kinney

Division of Pediatric Hematology/Oncology, Children's Hospital Boston, Boston, MA, 02115, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2011 in Tissue Engineering Part B: Reviews
Verified
Journal Article
Closed access
MKMelissa A. Kinney
Melissa A. Kinney
CSCarolyn Y. Sargent
Carolyn Y. Sargent
TMTodd C. McDevitt
Todd C. McDevitt
Stem cells possess the unique capacity to differentiate into many clinically relevant somatic cell types, making them a promising cell source for tissue engineering applications and regenerative medicine therapies. However, in order for the therapeutic promise of stem cells to be fully realized, scalable approaches to efficiently direct differentiation must be developed. Traditionally, suspension culture systems are employed for the scale-up manufacturing of biologics via bioprocessing systems that heavily rely upon various types of bioreactors. However, in contrast to conventional bench-scale static cultures, large-scale suspension cultures impart complex hydrodynamic forces on cells and aggregates due to fluid mixing conditions. Stem cells are exquisitely sensitive to environmental perturbations, thus motivating the need for a more systematic understanding of the effects of hydrodynamic environments on stem cell expansion and differentiation. This article discusses the interdependent relationships between stem cell aggregation, metabolism, and phenotype in the context of hydrodynamic culture environments. Ultimately, an improved understanding of the multifactorial response of stem cells to mixed culture conditions will enable the design of bioreactors and bioprocessing systems for scalable directed differentiation approaches.

8 February 2017 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
SDSergei Doulatov
Sergei Doulatov
LVLinda T. Vo
Linda T. Vo
EMElizabeth R. Macari
Elizabeth R. Macari
LWLara Wahlster
Lara Wahlster
MKMelissa A. Kinney
Melissa A. Kinney
GDGeorge Q. Daley
George Q. Daley
A stem cell reprogramming approach enables disease modeling and drug discovery for a genetic blood disorder and uncovers a candidate therapeutic.

1 July 2012 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Closed access
PBPriya R. Baraniak
Priya R. Baraniak
MCMarissa T. Cooke
Marissa T. Cooke
RSRabbia Saeed
Rabbia Saeed
MKMelissa A. Kinney
Melissa A. Kinney
KFKrista M. Fridley
Krista M. Fridley
TMTodd C. McDevitt
Todd C. McDevitt

8 October 2009 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
CSCarolyn Y. Sargent
Carolyn Y. Sargent
GBGeoffrey Y. Berguig
Geoffrey Y. Berguig
MKMelissa A. Kinney
Melissa A. Kinney
LHLuke A. Hiatt
Luke A. Hiatt
RCRichard L. Carpenedo
Richard L. Carpenedo
TMTodd C. McDevitt
Todd C. McDevitt

17 January 2018 in Nature
Verified
Journal Article
Closed access
PDF file
LVLinda T. Vo
Linda T. Vo
MKMelissa A. Kinney
Melissa A. Kinney
XLXin Liu
Xin Liu
YZYuannyu Zhang
Yuannyu Zhang
JBJessica Barragan
Jessica Barragan
GDGeorge Q. Daley
George Q. Daley

3 December 2013 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
MKMelissa A. Kinney
Melissa A. Kinney
THTracy A. Hookway
Tracy A. Hookway
YWYun Wang
Yun Wang
TMTodd C. McDevitt
Todd C. McDevitt